Tech Company Financing Transactions
AlphaVax Funding Round
AlphaVax, based in Research Triangle Park, secured $12.7 million in investment from private investors.
Transaction Overview
Company Name
Announced On
2/2/2007
Transaction Type
Venture Equity
Amount
$12,700,000
Round
Series E
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Triangle Dr.
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
AlphaVax has used its proprietary alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jonathan Gelles
Browse more venture capital transactions:
Prev: 2/2/2007: Farecast venture capital transaction
Next: 2/2/2007: A&G Pharmaceutical venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs